FAM110A and cancer: In view of the abnormal expression levels of FAM110A in tumors, the Kaplan–Meier method and COX regression analysis were conducted, and the results demonstrated that FAM110A may serve as a potential prognostic biomarker for a variety of cancers, especially LIHC.